Association between KLK3 rs2735839 G/A polymorphism and serum psa levels in Japanese men

Urologia Internationalis

Volumn 89, Issue 1, 2012, Pages 39-44

  Nobata, Syunsuke ^a   Hishida, Asahi ^b   Naito, Mariko ^b   Asai, Yatami ^c   Mori, Atsuyoshi ^a   Kuwabara, Mayumi ^a   Katase, Shiro ^d   Okada, Rieko ^b   Morita, Emi ^b   Kawai, Sayo ^b   Hamajima, Nobuyuki ^b   Wakai, Kenji ^b  

^a Seirei Preventive Health Care Center   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Mikatabara Beteru Home   (Japan)

^d Seirei Health Support Center   (Japan)

Author keywords

Kallikrein related peptidase 3; Prostate cancer; Prostate specific antigen; Single nucleotide polymorphism

Indexed keywords

KALLIKREIN RELATED PEPTIDASE 3; PEPTIDASE; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER RISK; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; KALLIKREINS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 84864608995     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000332197     Document Type: Article

References (33)

1. Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H: Trends and characteristics in prostate cancer mortality in Japan. Int J Urol 2000; 7:254-257. (Pubitemid 30440590)
2. Loeb S, Catalona WJ: Prostate-specific antigen screening: pro. Curr Opin Urol 2010; 20: 185-188.
3. Gudmundsson J, Besenbacher S, Sulem P, et al: Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med 2010; 2: 62ra92.
4. Gsur A, Preyer M, Haidinger G, et al: Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk. Carcinogen-esis 2002; 23: 1647-1651. (Pubitemid 35214950)
5. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK: Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008; 40:316-321. (Pubitemid 351311772)
6. Hamajima N, J-MICC Study Group: The Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study) to detect geneenvironment interactions for cancer. Asian Pac J Cancer Prev 2007; 8:317-323.
7. Asai Y, Naito M, Suzuki M, et al: Baseline data of Shizuoka area in the Japan Multi-institutional Collaborative Cohort Study (J-MICC Study). Nagoya J Med Sci 2009; 71: 137-144.
8. Tokudome S, Goto C, Imaeda N, Tokudome Y, Ikeda M, Maki S: Development of a data-based short food frequency questionnaire for assessing nutrient intake by middle-aged Japanese. Asian Pac J Cancer Prev 2004; 5:40-43.
9. Tokudome Y, Goto C, Imaeda N, et al: Relative validity of a short food frequency questionnaire for assessing nutrient intake versus three-day weighed diet records in middle-aged Japanese. J Epidemiol 2005; 15:135-145. (Pubitemid 41403851)
10. Goto C, Tokudome Y, Imaeda N, et al: Validation study of fatty acid consumption assessed with a short food frequency questionnaire against plasma concentration in middle-aged Japanese people. Scand J Nutr 2006; 50:77-82. (Pubitemid 43890860)
11. Imaeda N, Goto C, Tokudome Y, Hirose K, Tajima K, Tokudome S: Reproducibility of a short food frequency questionnaire for Japanese general population. J Epidemiol 2007; 17:100-107.
12. Hamajima N, Saito T, Matsuo K, Kozaki K, Takahashi T, Tajima K: Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 2000; 91: 865-868.
13. Xu J, Isaacs SD, Sun J, et al: Association of prostate cancer risk variants with clinico-pathologic characteristics of the disease. Clin Cancer Res 2008; 14: 5819-5824.
14. Hulka BS, Grimson RC, Greenberg BG, et al: 'Alternate' controls in a case-control study of endometrial cancer and exogenous estrogen. Am J Epidemiol 1980; 112: 376-387. (Pubitemid 10019228)
15. Grover VK, Cole DE, Hamilton DC: Attributing Hardy-Weinberg disequilibrium to population stratification and genetic association in case-control studies. Ann Hum Genet 2010; 74:77-87.
16. Ando R, Nagaya T, Hashimoto Y, et al: Inverse relationship between obesity and serum prostate-specific antigen level in healthy Japanese men: a hospital-based cross-sectional survey, 2004-2006. Urology 2008; 72: 561-565.
17. Culp S, Porter M: The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men. BJU Int 2009; 104:145 7-1461.
18. Blouin K, Veilleux A, Luu-The V, Tchernof A: Androgen metabolism in adipose tissue: Recent advances. Mol Cell Endocrinol 2009; 301: 97-103.
19. Kupelian V, Hayes FJ, Link CL, Rosen R, McKinlay JB: Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab 2008; 93: 3403-3410.
20. Habuchi T, Liqing Z, Suzuki T, et al: Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect. Cancer Res 2000; 60:5710-5713.
21. Lewis SJ, Murad A, Chen L, et al: Associations between an obesity-related genetic variant (FTO rs9939609) and prostate cancer risk. PLoS One 2010; 5:e134 85.
22. Whitaker HC, Kote-Jarai Z, Ross-Adams H, et al: The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS One 2010; 5:e13363.
23. Yeager M, Orr N, Hayes RB, et al: Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39:645-649. (Pubitemid 46676108)
24. Gudmundsson J, Sulem P, Manolescu A, et al: Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007; 39:631-637. (Pubitemid 46676102)
25. Freedman ML, Haiman CA, Patterson N, et al: Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci USA 2006; 103: 14068-14073. (Pubitemid 44452981)
26. Eeles RA, Kote-Jarai Z, Al Olama AA, et al: Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 2009; 41:1116-1121.
27. Ahn J, Berndt SI, Wacholder S, et al: Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet 2008; 40:1032-1034.
28. Pal P, Xi H, Sun G, et al: Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin. Hum Genet 2007; 122:251-259. (Pubitemid 47616533)
29. Lindstrom S, Schumacher F, Siddiq A, et al: Characterizing associations and SNP-envi-ronment interactions for GWAS-identified prostate cancer risk markers-results from BPC3. PLoS One 2011; 6:e17142.
30. Gallagher DJ, Vijai J, Cronin AM, et al: Susceptibility loci associated with prostate cancer progression and mortality. Clin Cancer Res 2010; 16:2819-2832.
31. Pampalakis G, Sotiropoulou G: Tissue kal-likrein proteolytic cascade pathways in normal physiology and cancer. Biochim Biophys Acta 2007; 1776:22-31. (Pubitemid 47332073)
32. Database of Single Nucleotide Polymorphisms (dbSNP) homepage (http://www.ncbi.nlm.nih.gov/snp).
33. Takata R, Akamatsu S, Kubo M, et al: Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat Genet 2010; 42: 751-754.